Interact to see
Advertisement
Advertisement
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
American Beacon ARK Transfmt Innov R6
Price$21.95
Change-$0.25 (-1.13%)
VolumeN/A
Net Assets203.31M
Fidelity Extended Market Index
Price$102.71
Change-$0.26 (-0.25%)
VolumeN/A
Net Assets41.03B
ADNRX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. FSMAX commentary
Dec 28, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and FSMAX is a Hold.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41B vs. ADNRX (203M). FSMAX pays higher dividends than ADNRX: FSMAX (0.43) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (5 years) vs FSMAX (14 years). ADNRX (1.18) is less costly to investors than FSMAX (0.04). ADNRX is a more actively managed with annual turnover of: 46.00 vs. FSMAX (15.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. ADNRX annual gain was more profitable for investors over the last year : 31.12 vs. FSMAX (10.55). FSMAX return over 5 years is better than : 26.24 vs. ADNRX (-53.77).
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | 1.05 | 0.04 | 3,000% |
| Annual Report Gross Expense Ratio | 1.18 | 0.04 | 3,371% |
| Fund Existence | 5 years | 14 years | - |
| Gain YTD | 40.795 | 13.303 | 307% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 203M | 41B | 0% |
| Annual Yield % from dividends | 0.00 | 0.43 | - |
| Returns for 1 year | 31.12 | 10.55 | 295% |
| Returns for 3 years | 169.66 | 67.63 | 251% |
| Returns for 5 years | -53.77 | 26.24 | -205% |
| Returns for 10 years | N/A | 118.30 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers